首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Letter by Asinger et al Regarding Articles, 'Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke' and 'Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA(2)DS(2)-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum'
【24h】

Letter by Asinger et al Regarding Articles, 'Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke' and 'Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA(2)DS(2)-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum'

机译:Asinger等人关于文章的信,“房颤和1个中风危险因素(CHA(2)DS(2)-VASc男性得分1,女性2分)的患者应抗凝吗?是:甚至有1个中风危险因子发生中风的真正风险”和“应将具有房颤和1个中风危险因素(CHA(2)DS(2)-VASc男性为1,女性为2)的患者抗凝治疗吗?:CHA(2)DS(2 )-VASc 1难题:风险范围较低端的决策”

获取原文
获取原文并翻译 | 示例
       

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号